^{_{Welcome to the TraderTV Live Morning Research Note. Here's what's making major moves in the market today.}}

0830 - NY Fed manufacturing index for March: Expected 3.9; Prior 7.1
1000 - NAHB housing market index for March: Expected 37; Prior 36

NVIDIA Corp (NVDA)

+1.11%

The company’s annual GTC event begins on Monday, March 16 with a keynote from CEO Jensen Huang at 1:00 PM ET. Huang is expected to outline Nvidia’s upcoming AI hardware, software platforms, and strategy. The event may feature new chips, including potential inference technology tied to Groq, and could include the introduction of Nvidia’s first Arm-based laptop CPUs aimed at gaming-focused Windows devices.

Crypto Stocks

+3.43%

Trading sharply higher premarket in tandem with Bitcoin, which is looking to continue its two-week green streak. The cryptocurrency traded as high as $74,400 on Monday morning, marking its highest level in over a month, before pulling back to the $73,700 area as of 7:10 AM ET. Ethereum similarly traded at multiweek highs of $2,275 to start Monday’s session.

COIN, MSTR, MARA, RIOT, IBIT, ETHE, HUT, CLSK, IREN, CAN, HIVE

Nebius Group NV (NBIS)

+14.47%

Gapping up after announcing that its U.S. subsidiary signed a five-year AI infrastructure agreement with Meta Platforms worth up to $27 billion, including $12 billion in dedicated GPU capacity beginning in 2027 and up to $15 billion in optional compute capacity using Nvidia’s Vera Rubin platform. The deal strengthens Nebius’s long-term AI cloud partnership with Meta. Nebius noted that its 2026 guidance is unchanged since most financial impact is expected after 2026.

Meta Platforms Inc (META)

+2.83%

Reuters reported that the company is considering sweeping layoffs that could impact 20% or more of its workforce as it looks to offset heavy spending on AI infrastructure and improve efficiency through AI-assisted work. If implemented, the cuts would be the company’s largest since its 2022–2023 “year of efficiency” restructuring and could affect tens of thousands of employees from its roughly 79,000-person workforce.

Oil and Energy Stocks

+0.33%

On watch as a group as geopolitical tensions in the Middle East continue to unfold. On Friday, US President Donald Trump ordered US strikes on Iranian military assets on Kharg Island; Trump later warned that oil infrastructure could be targeted if Iran continues disrupting the Strait of Hormuz. Separately, the Wall Street Journal reported that the US may soon lead a coalition to escort ships through the strait.

USO, CVX, XOM, OXY, DVN, COP, EONR, BATL, TPET

Memory Stocks

+4.04%

Reuters reported that Micron plans to build a second semiconductor manufacturing facility in Tongluo, Taiwan after acquiring the P5 site from Powerchip Semiconductor Manufacturing Corp.. The new fab will expand production of advanced DRAM and high-bandwidth memory for AI demand, with construction expected to begin by the end of fiscal 2026.

MU, SNDK, STX, WDC

Alibaba Group Holding Ltd (BABA)

+2.73%

Bloomberg reported that the company is creating a new AI division called Alibaba Token Hub, led by CEO Eddie Wu. This decision is designed to unify Alibaba’s AI research, apps, and products—including the Qwen models, DingTalk, and Quark devices—under one organization. The move aims to accelerate development and better monetize AI services as Chinese firms struggle to generate profits from AI compared with Western rivals like OpenAI and Anthropic. Alibaba is set to report quarterly earnings before the bell on Thursday, March 19. Separately, US Treasury Secretary Scott Bessent indicated that a meeting between President Trump and President Xi of China could be delayed if the US remains involved in tensions in Iran.

Tesla Inc (TSLA)

+0.97%

CEO Elon Musk said the company’s Terafab project to manufacture AI chips is expected to launch within a week as Tesla advances development of its fifth-generation AI5 chip for autonomous driving. Tesla is working with partners including TSMC, Samsung Electronics, and potentially Intel to produce the chips that power its Full Self-Driving systems.

Alphabet Inc (GOOGL)

+0.19%

Reuters reported that European publishers and tech groups, including members of the European Publishers Council, urged EU regulators to conclude a nearly two-year antitrust probe into Alphabet’s Google over alleged favoritism toward its own services in search. These groups are also reportedly looking for regulators to impose a fine against Google in this case. The request highlights ongoing tensions between the European Union and Washington over stricter regulations targeting the market power of major US tech companies.

Sable Offshore Corp (SOC)

+6.36%

Trading sharply higher premarket after the company announced it has resumed crude shipments from its Santa Ynez unit through the Santa Ynez pipeline. This resumption follows a federal order under the Defense Production Act. Sable Offshore expects an initial flow of about 50,000 barrels per day from its Las Flores Canyon facility, targeting first sales by April 1.

Upstart Holdings Inc (UPST)

+3.19%

BTIG upgraded the stock to Buy with a $43 price target, citing potential upside from the company’s plan to pursue a national bank charter. The firm believes a deposit-funded banking model could reduce transaction costs, expand the customer base nationwide, and potentially boost earnings significantly while lowering liquidity risk tied to private credit funding.

Dollar Tree Inc (DLTR)

-1.03%

Trading lower premarket following its Q4 2026 earnings report. Revenue of $5.5 billion beat estimates of $5.46 billion, while earnings of $2.56 per share beat estimates of $2.53. The company guided revenue between $20.5 billion and $20.7 billion for FY 2027, compared to estimates of $20.7 billion. Its EPS outlook for the fiscal year was $6.50-$6.90, compared to expectations of $6.74.

CytomX Therapeutics Inc (CTMX)

+54.06%

Gapping up after reporting Phase 1 expansion data for its EpCAM-targeting antibody-drug conjugate varsetatug masetecan in late-line metastatic colorectal cancer. This data showed confirmed response rates of 20% at 8.6 mg/kg and 32% at 10 mg/kg, with median progression-free survival of roughly seven months. The study, which included heavily pretreated patients, also showed an 88% disease control rate. Approximately 14.2% of CytomX’s 132.47 million-share float is sold short.